Amplify Etf Profile
Amplify is selling at 19.16 as of the 28th of November 2024; that is 0.62% down since the beginning of the trading day. The etf's lowest day price was 19.16. Equity ratings for Amplify are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 28th of November 2024. Click here to learn more.
Amplify Etf Highlights
Old Name | Amplify ETF Trust |
Business Concentration | Health, ETFMG (View all Sectors) |
Country Name | USA |
Returns Y T D | (7.6) |
Name | Amplify ETF Trust |
Currency Code | USD |
Open Figi | BBG00VCZBR80 |
In Threey Volatility | 30.27 |
1y Volatility | 23.92 |
200 Day M A | 18.5383 |
50 Day M A | 18.9416 |
Code | GERM |
Updated At | 7th of September 2024 |
Currency Name | US Dollar |
In Threey Sharp Ratio | (0.41) |
Type | ETF |
Amplify [GERM] is traded in USA and was established 2020-06-17. The fund is listed under Health category and is part of ETFMG family. Amplify currently have 21.76 M in assets under management (AUM). , while the total return for the last 3 years was -23.8%.
Check Amplify Probability Of Bankruptcy
Top Amplify Etf Constituents
ADPT | Adaptive Biotechnologies Corp | Stock | Health Care | |
ALNY | Alnylam Pharmaceuticals | Stock | Health Care | |
AVIR | Atea Pharmaceuticals | Stock | Health Care | |
BIO | Bio Rad Laboratories | Stock | Health Care | |
DGX | Quest Diagnostics Incorporated | Stock | Health Care | |
EBS | Emergent Biosolutions | Stock | Health Care | |
IMAB | I Mab | Stock | Health Care | |
INO | Inovio Pharmaceuticals | Stock | Health Care |
Amplify Against Markets
Amplify Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amplify etf to make a market-neutral strategy. Peer analysis of Amplify could also be used in its relative valuation, which is a method of valuing Amplify by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
The market value of Amplify is measured differently than its book value, which is the value of Amplify that is recorded on the company's balance sheet. Investors also form their own opinion of Amplify's value that differs from its market value or its book value, called intrinsic value, which is Amplify's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amplify's market value can be influenced by many factors that don't directly affect Amplify's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amplify's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amplify is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amplify's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.